Welcome to the
MPH Mittelständische Pharma Holding AG
The MPH Mittelständische Pharma Holding AG is a stock exchange listed company whose focus is on the growth segments in the pharmaceutical industry.
The Pharma segment consists of the portfolio business of HAEMATO PHARM AG. HAEMATO PHARM AG focuses on the therapeutic areas oncology, HIV, rheumatism, neurology and cardiovascular diseases. With the growth segments Generics as well as with EU import medicines, we offer high-quality and innovative preparations allowing for an affordable medication therapy without any quality cutbacks. Here, we still see strong growth.
The new segment Healthcare comprises the activities bundled in the Healthcare Services GmbH. In this segment, the veterinary portfolio business of HAEMATO Vet GmbH and the new business of Healthcare Solutions GmbH (consulting services for pharmacies) and Nutri Care GmbH (consulting services for nutrition subjects) are organized. In addition, Simgen GmbH (generics and foreign business) and Pharmigon GmbH (production of patient-individual medications) from the investment in Windsor AG are included here. The area of healthcare real estate is in the project planning phase within the segment of Windsor AG.
The Healthcare activities are not subject to the German compulsory manufacturer discount and yield high margins.
Through this double competence and the strategic positioning, the group is able to flexibly react to changes in the pharmaceuticals market that might potentially emerge, e.g. through legal measures of regulation.
MPH understands itself as a partner in the cost-conscious supply of medicines and makes a precious contribution to keeping health affordable!